Your browser doesn't support javascript.

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Home > Búsqueda > ()
XML
Imprimir Exportar

Formato de exportación:

Exportar

Email
Adicionar mas contactos
| |

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.

Volz, Erik; Hill, Verity; McCrone, John T; Price, Anna; Jorgensen, David; O'Toole, Áine; Southgate, Joel; Johnson, Robert; Jackson, Ben; Nascimento, Fabricia F; Rey, Sara M; Nicholls, Samuel M; Colquhoun, Rachel M; da Silva Filipe, Ana; Shepherd, James; Pascall, David J; Shah, Rajiv; Jesudason, Natasha; Li, Kathy; Jarrett, Ruth; Pacchiarini, Nicole; Bull, Matthew; Geidelberg, Lily; Siveroni, Igor; Goodfellow, Ian; Loman, Nicholas J; Pybus, Oliver G; Robertson, David L; Thomson, Emma C; Rambaut, Andrew; Connor, Thomas R.
Cell; 2020 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-33275900
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G are suggestive of a selective advantage but may also be due to a random founder effect. We investigate the hypothesis for positive selection of spike D614G in the United Kingdom using more than 25,000 whole genome SARS-CoV-2 sequences. Despite the availability of a large dataset, well represented by both spike 614 variants, not all approaches showed a conclusive signal of positive selection. Population genetic analysis indicates that 614G increases in frequency relative to 614D in a manner consistent with a selective advantage. We do not find any indication that patients infected with the spike 614G variant have higher COVID-19 mortality or clinical severity, but 614G is associated with higher viral load and younger age of patients. Significant differences in growth and size of 614G phylogenetic clusters indicate a need for continued study of this variant.